Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials.
Raskob GE, Gallus AS, Pineo GF, Chen D, Ramirez LM, Wright RT, Lassen MR. Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials. J Bone Joint Surg Br. 2012 Feb; 94(2):257-64.
-
Administration, Oral
-
Administration, Oral
-
Aged
-
Aged
-
Anticoagulants
-
Anticoagulants
-
Arthroplasty, Replacement, Hip
-
Arthroplasty, Replacement, Hip
-
Arthroplasty, Replacement, Knee
-
Arthroplasty, Replacement, Knee
-
Double-Blind Method
-
Double-Blind Method
-
Drug Administration Schedule
-
Drug Administration Schedule
-
Enoxaparin
-
Enoxaparin
-
Female
-
Female
-
Fibrinolytic Agents
-
Fibrinolytic Agents
-
Humans
-
Humans
-
Injections, Subcutaneous
-
Injections, Subcutaneous
-
Male
-
Male
-
Middle Aged
-
Middle Aged
-
Perioperative Care
-
Perioperative Care
-
Postoperative Hemorrhage
-
Postoperative Hemorrhage
-
Pyrazoles
-
Pyrazoles
-
Pyridones
-
Pyridones
-
Randomized Controlled Trials as Topic
-
Randomized Controlled Trials as Topic
-
Treatment Outcome
-
Treatment Outcome
-
Venous Thromboembolism
-
Venous Thromboembolism